As of August 28, 2026, Orchestra BioMed Holdings, Inc. (OBIO) has a DilutionWatch DilutionScore of 45/100, rated MEDIUM dilution risk. Orchestra BioMed Holdings, Inc. has a market capitalization of $234.13M, 60.11M shares outstanding, 66 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 7%
🔁 Convertible Conversion
model 15%
• Convertible debt present: 8.7% potential dilution
Market Data
Market Cap$234.13M
Shares Outstanding60.11M
Float33.55M
Cash$109.96M
Debt$15.00M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 39.7% shares (2026Q1 vs prior)
66 institutional holders · 30.76M shares
#1
PERCEPTIVE ADVISORS LLC
10.08M shares
#2
RTW INVESTMENTS, LP
8.31M shares
#3
VANGUARD CAPITAL MANAGEMENT LLC
4.41M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest2.43M
Days to Cover13.4
% of Float7.2%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2026-06-30
xbrl
XBRL WARRANT
2025-12-31
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual OBIO Dilution Snapshot
Orchestra BioMed Holdings, Inc. (OBIO) has a DilutionScore of 45/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for OBIO: xbrl on 2026-06-30; xbrl on 2025-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track OBIO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking OBIO — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for OBIO
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.